Lymphoma Large B Cell Diffuse clinical trials

Explore recruiting lymphoma large b cell diffuse clinical trials.

Recruiting lymphoma large b cell diffuse studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lymphoma Large B Cell Diffuse trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A safety study of PF-08046044/SGN-35C in adults with advanced cancers

France, Spain, Denmark, Germany, Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Lymphoma Large B Cell Diffuse trials by city

Lymphoma Large B Cell Diffuse clinical trials

Recruiting lymphoma large b cell diffuse studies right now

Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.

A Study of NX-1607 in Adults With Advanced Malignancies

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

CHiR Therapy for Elderly DLBCL Intolerant to Chemo

Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL

Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma

DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

Also recruiting in Europe

A safety study of PF-08046044/SGN-35C in adults with advanced cancers

Lymphoma Large B Cell Diffuse trials by city

Other conditions